Contact
searchSearch
HMP Global

Infection News

FDA Alert
News
FDA Approves New Oral Treatment to Prevent C.Diff Recurrence
05/01/2023
Priyam Vora
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug Administration approved Vowst, the first fecal microbiota product that is taken orally for the prevention of recurrence of Clostridioides difficile infection among adults.
The U.S. Food and Drug...
05/01/2023
Gastroenterology
News
Gastrointestinal Symptoms Common in Patients Hospitalized With COVID-19
08/08/2022
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among patients with COVID-19 were associated with increased risk of intensive care and mortality, according to a new study.
Elevated liver enzymes among...
08/08/2022
Gastroenterology
News
ACG Releases New Guideline on C Diff
05/21/2021
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of Gastroenterology updated its 2013 guideline on the diagnosis, treatment, and prevention of Clostridioides difficile to reflect changes in nomenclature, diagnostic methods, and treatments, including fecal microbial...
The American College of...
05/21/2021
Gastroenterology
News
Researchers Study Potential Risks of FMT
04/21/2021
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation is widely used and considered safe in treating Clostridioides difficile infection.
Fecal microbiota transplantation...
04/21/2021
Gastroenterology
News
GI Infections May Lead to Microscopic Colitis
04/21/2021
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to increased risk of microscopic colitis diagnosis, research reveals.
Gastroenteritis can be linked to...
04/21/2021
Gastroenterology
News
Severe Course of COVID-19 May Be Associated With Poor GI Health
01/13/2021
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing evidence that altered gut microbiota and ‘leaky gut’ are connected to the severity of cases of COVID-19.
A new review reveals growing...
01/13/2021
Gastroenterology

News

Research Review
New Meta-Analysis Highlights Burden of MASLD Among IBD Patients
02/03/2026
Rebecca Mashaw
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from more than 1.5 million individuals, providing the most extensive evidence yet on MASLD’s prevalence and associated factors in patients with Crohn’s disease and ulcerative colitis.
The study draws on data from...
02/03/2026
Gastroenterology
Emerging Therapies
EC Plus FOLFIRI Improves Response Rates in First-Line BRAF V600E–Mutant Metastatic Colorectal Cancer
01/14/2026
Jessica Garlewicz
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating mCRC, EC plus FOLFIRI offers a highly active first-line strategy for patients with BRAF V600E–mutant disease and may represent a new standard of care in this setting.
For gastroenterologists treating...
01/14/2026
Gastroenterology
Research Highlights
Short Course Radiation and ctDNA for Rectal Cancer
01/14/2026
Jessica Garlewicz
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the ASTRO meeting, investigators indicated that circulating tumor DNA may predict recurrence of rectal cancer following short-course radiation therapy.
In an abstract presented at the...
01/14/2026
Gastroenterology
Research Highlights
Cumulative Social Risk Linked to Poorer Survival in Stage III Colorectal Cancer
01/14/2026
Jessica Garlewicz
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found that each additional social risk factor significantly increased the likelihood of cancer-specific mortality among patients with advanced colorectal cancer.
A prospective cohort study found...
01/14/2026
Gastroenterology
Research Highlights
Persistent MASLD Greatly Increases Diabetes and Cardiovascular Risks, Study Finds
12/15/2025
Rebecca Mashaw
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links temporal changes in metabolic-associated steatotic liver disease status to markedly different risks for type 2 diabetes, cardiovascular events, and mortality.
A major cohort study links...
12/15/2025
Gastroenterology
Research Highlights
Sex-Specific Risks Highlight MASLD Burden Across Women’s Lifespan
12/11/2025
Rebecca Mashaw
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD disproportionately affects women, with key risks linked to PCOS, menopause, and pregnancy.
A new review details how MASLD...
12/11/2025
Gastroenterology
Conference Coverage
Resmetirom Reduces Portal Hypertension Risk and Fibrosis Markers in MASH Cirrhosis at 2 Years
11/04/2025
Jessica Garlewicz
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients with confirmed F4 fibrosis at baseline demonstrated regression to F3 by year 2 of treatment with resmetirom for MASH cirrhosis.
More than one-third of patients...
11/04/2025
Gastroenterology
Conference Coverage
Tirzepatide Bests Semaglutide in Reducing Cardiovascular Events and Mortality in Patients With MASLD/MASH
11/04/2025
Jessica Garlewicz
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was associated with lower risks of cardiovascular-related outcomes, all-cause mortality, and all-cause hospitalizations compared to semaglutide in a large real-world study, according to an abstract presented at the ACG...
Tirzepatide treatment was...
11/04/2025
Gastroenterology
Conference Coverage
E-Cigarette Use and Risk of Peptic Ulcer Disease: Findings from a National Cohort
10/27/2025
Rebecca Mashaw
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at the ACG meeting, investigators concluded that e-cigarette use—both current and former—is independently associated with a risk of peptic ulcer disease.
In an oral abstract presented at...
10/27/2025
Gastroenterology
Research Highlights
Liquid Biopsy Shows Potential in Cholangiocarcinoma Care
10/09/2025
Rebecca Mashaw
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights liquid biopsy’s emerging role in diagnosis and management of biliary tract cancers.
A recent review highlights...
10/09/2025
Gastroenterology

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use